The Fight Against COVID19
23.82k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
TREA analyzes over 100 million data points, interactions, relationships on company research and development activities, allowing investors to quickly gain insight without having to go through complex regulatory filings. Primary data sources include: FDA (Food and Drug Administration), NIH (National Institutes of Health), USPTO (US Patent and Trademark Office). The search parameters for generating this watchlist were (1) Above sector average Innovation Index score, (2) IP history at least 5 years (3) COVID19 (4) 2019-nCov (5) SARS-CoV-2 among others.
Performance
| Watchlist | Change Today | 1 Month Return | 1 Year Return | Total Return |
|---|---|---|---|---|
| The Fight Against COVID19 | +0.97% | - | - | - |
| ^GSPC | +1.03% | +4.94% | +28.98% | +5599.76% |
14 Symbols
| Symbol | Company Name | Last Price | Change | % Change | Market Time | Volume | Avg Vol (3 month) | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 152.395 | +1.01 | +0.67% | 2:54 p.m. EDT | 2.61M | 7.52M | 366.77B |
| ABBV | AbbVie Inc. | 163.5 | +1.91 | +1.18% | 2:54 p.m. EDT | 2.70M | 5.66M | 288.72B |
| PFE | Pfizer Inc. | 28.79 | +0.41 | +1.44% | 2:54 p.m. EDT | 21.81M | 42.74M | 163.49B |
| SNY | Sanofi | 48.93 | -0.57 | -1.15% | 2:54 p.m. EDT | 3.78M | 1.98M | 125.61B |
| REGN | Regeneron Pharmaceuticals, Inc. | 978.271 | -6.37 | -0.65% | 2:54 p.m. EDT | 352.47k | 453.61k | 106.95B |
| GSK | GSK plc | 45.74 | +0.08 | +0.18% | 2:54 p.m. EDT | 2.64M | 3.15M | 93.58B |
| GILD | Gilead Sciences, Inc. | 67.52 | -0.13 | -0.19% | 2:54 p.m. EDT | 2.49M | 7.15M | 84.12B |
| MRNA | Moderna, Inc. | 128.66 | +0.34 | +0.26% | 2:54 p.m. EDT | 1.82M | 3.86M | 49.31B |
| TAK | Takeda Pharmaceutical Company Limited | 13.435 | -0.01 | -0.11% | 2:54 p.m. EDT | 673.75k | 1.67M | 42.16B |
| BNTX | BioNTech SE | 92.46 | +0.18 | +0.20% | 2:53 p.m. EDT | 329.63k | 595.48k | 22.39B |
| NVAX | Novavax, Inc. | 12.81 | -0.67 | -4.97% | 2:54 p.m. EDT | 21.28M | 12.19M | 1.89B |
| VIR | Vir Biotechnology, Inc. | 10.015 | -0.06 | -0.64% | 2:54 p.m. EDT | 383.54k | 1.00M | 1.36B |
| INO | Inovio Pharmaceuticals, Inc. | 12.915 | +1.49 | +13.09% | 2:53 p.m. EDT | 540.17k | 440.23k | 334.58M |
Motley Fool1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell?
A potentially very lucrative arrangement with a peer doesn't necessarily make the company a buy.
Motley Fool1 No-Brainer Growth Stock to Buy and Hold for 10 Years
This company's potential far outweighs its risks.
Motley Fool2 Incredible Growth Stocks to Buy Hand Over Fist Right Now
These two healthcare stocks may be deeply undervalued.
Sign in to view your followed lists
© 2024 Yahoo. All rights reserved.